← All trials
NCT00288067
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2005
- Primary completion
- Jul 1, 2013
- Completion date
- Jul 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 32
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- National Cancer Institute (NCI)Lead sponsor
- University of WashingtonOverall official - principal investigator
Drugs studied
Indications studied
- Burkitt Lymphoma
- Hodgkin Disease
- Lymphoma, Follicular
- Waldenstrom Macroglobulinemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia-Lymphoma, Adult T-Cell
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Mantle-Cell
- Lymphoma, Primary Cutaneous Anaplastic Large Cell
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.